294 filings
Page 4 of 15
8-K
e3yn rjoiblhdv9vv
19 Jun 20
Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package
9:09am
8-K
lyjah
30 Apr 20
Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA
4:22pm
8-K
7hqlx3eu2nj74
20 Apr 20
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
4:05pm
8-K
euf6gbo0j
1 Apr 20
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
5:12pm
6-K
wuh4lkki4wp snbzk
11 Mar 20
Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico
8:00am
6-K
aonqg1q mu40bgrdnl
28 Feb 20
Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements
5:00pm
6-K
f9zte3pd mrj5w975
14 Feb 20
Current report (foreign)
8:00am
6-K
glw4tgukjpbik00
14 Feb 20
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020
8:00am
6-K
m0wdb9iwh
13 Feb 20
Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call
9:00am
6-K
budy rs4k8h4l0
10 Feb 20
Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre
7:00am
6-K
azm2gn4 s58q
13 Jan 20
Acasti Pharma Reports Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
6:21am
6-K
1grdl5q936 4dne2g50
23 Dec 19
Acasti Pharma Provides Update on Timing of Topline Results for TRILOGY 1 Phase 3 Trial of CaPre
8:43pm
6-K
4bxa5n3al6k0fl1n96
26 Nov 19
Acasti Pharma Reports Last Patient Visit in TRILOGY 1 Phase 3 Trial of CaPre for the Treatment of Severe Hypertriglyceridemia
7:58am
6-K
blt6lbv0ruqp
18 Nov 19
Current report (foreign)
8:46am
6-K
dp8li2tuk7o5w0a
13 Nov 19
Current report (foreign)
7:55am
6-K
fql0mdf afmt3r2
13 Nov 19
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2020
7:55am
6-K
uq79z97xoyy
7 Nov 19
Acasti Pharma Announces Publication of CaPre Pharmacokinetics Study in a Leading Peer-Reviewed Journal
8:42am
6-K
4viz8y67c3x79
6 Nov 19
Acasti Pharma Schedules Second Quarter Fiscal 2020 Conference Call
9:39am
6-K
8tb2jfpb
4 Nov 19
Agreement provides Acasti long-term supply of raw krill oil through commercialization
9:24am
6-K
mt5hvrz5v 7qz2
1 Oct 19
Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
9:00am